# Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia

> **NCT01576185** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 10 (actual)

## Conditions studied

- Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

## Interventions

- **OTHER:** laboratory biomarker analysis
- **DRUG:** quizartinib
- **DRUG:** sorafenib tosylate

## Key facts

- **NCT ID:** NCT01576185
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576185, "Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01576185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*